---
schema_version: "secwatch.filing_event.v1"
accession: "0001566469-23-000059"
form_type: "8-K"
ticker: null
cik: "0001566469"
company_name: "NantHealth, Inc."
filed_at: "2023-09-13T23:59:59+00:00"
generated_at: "2026-06-10T19:03:20.995059+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NantHealth appoints Rao Haris Naseem as CEO; Patrick Soon-Shiong remains Chairman

## Summary
- Dr. Rao Haris Naseem appointed CEO and board member effective September 7, 2023.
- Founder Patrick Soon-Shiong steps down as CEO but continues as Chairman.
- Base salary set at $35,568; eligible for discretionary bonus; option to purchase 1,000,000 shares subject to board approval.
- Naseem's affiliate Summus Holdings purchased 3,846,154 shares ($1.5M) in a private placement closed August 30, 2023.
- Employment is at-will; vesting of stock options accelerated 100% upon change in control.

## SEC filing metadata
- accession: 0001566469-23-000059
- form_type: 8-K
- cik: 0001566469
- company_name: NantHealth, Inc.
- filed_at: 2023-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/0001566469-23-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/nh-20230907.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001566469-23-000059
- JSON: https://secwatch.observer/filing/0001566469-23-000059.json
- Plain text: https://secwatch.observer/filing/0001566469-23-000059.txt

## Key facts
- Executive change
  Patrick Soon-Shiong changed role as Chairman of the Board at NantHealth, Inc..
  - Action: transitioned out of CEO role
  - Role: Chairman of the Board
  source text: In connection with Dr. Naseem’s appointment as CEO, Patrick Soon-Shiong, M.D. transitioned out of his role as CEO of the Company and will continue to serve as Chairman of the Board as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/0001566469-23-000059-index.htm
- Executive change
  Rao Haris Naseem was appointed as Chief Executive Officer at NantHealth, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On September 7, 2023, the Board of Directors (the “Board”) of NantHealth, Inc. (the “Company”) appointed Rao Haris Naseem, M.D., FACC, FHRS as the Company’s Chief Executive Officer (“CEO”) and a member of the Board, effective September 7, 2023 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/0001566469-23-000059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.